查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1832026

2025 年至 2033 年家禽疫苗市場規模、佔有率、趨勢及預測（按疾病、產品、劑型、應用、最終用戶和地區分類）

Poultry Vaccines Market Size, Share, Trends and Forecast by Disease, Product, Dosage Form, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球家禽疫苗市場規模達20億美元。展望未來， IMARC Group預計到2033年，市場規模將達到33億美元，2025-2033年期間的複合年成長率（CAGR）為5.31%。家禽疾病預防意識的不斷增強、對安全無病家禽產品的需求不斷成長，以及為確保永續生產而不斷改進的疫苗開發技術，是推動家禽疫苗市場佔有率成長的主要因素。

家禽疫苗是專門為保護家禽（例如雞、鴨和火雞）免受傳染病侵害而設計的生物製品。其配方旨在觸發家禽的免疫反應，使其對特定病原體（包括病毒和細菌）產生免疫力。疫苗接種可以透過多種途徑進行，例如注射、氣霧劑或透過家禽的飲用水進行。疫苗接種計劃會根據特定地區流行的疾病風險進行客製化，是家禽養殖場生物安全措施的重要組成部分。此外，透過使用合適的家禽疫苗，養殖戶可以有效緩解疾病爆發，並確保家禽產品的永續安全生產。如今，家禽疫苗對於維護家禽族群的健康和福祉至關重要。

市場主要受生物製品需求成長的驅動。此外，對家禽產品（包括肉類和蛋類）需求的不斷成長也促進了家禽產量的增加，從而推動了市場的成長。同時，不斷成長的家禽數量使得使用疫苗來保護禽類並維持產量水平成為必要，這也促進了市場的成長。此外，家禽養殖戶和生產者越來越意識到預防性醫療措施（包括疫苗接種）對於確保禽群健康和生產力的重要性，這也是另一個重要的成長促進因素。此外，疫苗接種被認為是一種經濟有效的控制和預防傳染病傳播的方法，可以減少對抗生素和其他治療的需求，從而推動市場的成長。此外，政府推出的多項強調食品安全和動物福利的政策也加速了市場的成長。此外，疫苗技術和研究的進步促進了更有效、更有針對性的疫苗的開發，提高了疫苗的有效性和安全性，從而創造了積極的市場前景。

家禽疫苗市場趨勢/促進因素：

家禽消費量不斷增加

雞肉、肉類和蛋類等家禽產品需求的不斷成長，正在影響家禽疫苗市場的前景。此外，人口成長、快速城鎮化和人們忙碌的生活方式也推動了對家禽產品的需求，從而促進了市場的成長。此外，家禽養殖戶正將疫苗接種作為預防措施，以保護他們的家禽，並確保穩定供應安全無病的產品，這是另一個重要的成長誘因。此外，疫苗提供了一種有效且高效的方法來保護家禽免受傳染病的侵害，從而降低了疫情爆發的可能性和相關的生產損失，從而加速了市場的成長。此外，養殖戶可以透過為家禽接種疫苗來提高家禽的健康和生產力，從而提高家禽業的效率和獲利能力，從而推動市場的成長。此外，家禽消費量的不斷成長也帶動了家禽及其產品國際貿易的成長，從而推動了市場的成長。

疾病預防意識不斷增強

家禽疫苗市場的另一個重要趨勢是家禽族群中傳染病發病率的上升，這促使農民和生產者廣泛採用疫苗來實施預防措施保護禽類，進而影響市場成長。此外，農民擴大投資於疫苗接種計劃，以保護他們的投資，控制疾病，並幫助降低家禽傳染病的發病率和嚴重程度，這是另一個重要的成長誘因。此外，農民可以透過為禽類接種疫苗來防止疾病傳播並最大限度地減少生產損失，確保持續供應健康的家禽產品以滿足消費者的需求，從而加速市場成長。同時，人們的健康意識日益增強，對安全優質食品的需求不斷成長，這在疫苗的幫助下促進了安全健康的家禽產品的生產，從而推動了市場成長。此外，消費者對接種疫苗家禽益處的認知不斷提高，進一步推動了對家禽疫苗的需求，鼓勵生產者將疫苗接種作為其疾病預防策略中的一個重要方面。

疫苗研發領域的新興技術進步

現代疫苗的研發使得生產出效力更高、免疫力更持久的疫苗成為可能，從而能夠更好地預防多種家禽疾病，從而促進家禽疫苗市場的成長。此外，生物技術、創新方法和技術的不斷發展，正在催生出更有效、更安全、更有針對性的家禽疫苗，這也是另一個重要的成長促進因素。此外，隨著佐劑和基於載體的疫苗等疫苗輸送系統的廣泛進步，家禽疫苗現在可以引發更強大、更特異的免疫反應，從而加速市場成長。同時，這些突破性進展促進了客製化疫苗的開發，以滿足不同家禽品種的特定需求和應對區域性疾病挑戰，從而推動了市場成長。此外，疫苗配方的進步使得疫苗更加穩定、耐溫性更強，從而延長了疫苗的保存期限，減少了對冷鏈儲存和運輸的需求，使家禽養殖戶（尤其是在偏遠或資源匱乏的地區）更容易獲得疫苗，從而創造了積極的市場前景。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球家禽疫苗市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依疾病

  • 傳染性支氣管炎
  • 禽流感
  • 新城疫
  • 馬立克氏症
  • 其他

第7章：市場區隔：依產品

  • 重組疫苗
  • 減毒活疫苗
  • 去活化疫苗
  • 亞單位疫苗
  • 其他

第8章：市場區隔：按劑型

  • 液體疫苗
  • 凍乾疫苗

第9章：市場區隔：依應用

  • 飼養員
  • 肉雞
  • 層

第 10 章：市場區隔：依最終用戶

  • 獸醫院
  • 家禽公司
  • 家禽疫苗接種中心

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 12 章：SWOT 分析

第 13 章：價值鏈分析

第 14 章：波特五力分析

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AniCon Labor GmbH (SAN Group)
    • Biovac Ltd.
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco
    • Hester Biosciences Limited
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Venkys India
    • Zoetis Inc.
Product Code: SR112025A4547

The global poultry vaccines market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.31% during 2025-2033. The growing awareness of disease prevention among poultry, the increasing demand for safe and disease-free poultry products, and the continuous technological advancements in vaccine development to ensure sustainable production are major factors driving the poultry vaccines market share.

Poultry vaccines are biological products specifically designed to protect domestic birds, such as chickens, ducks, and turkeys, from infectious diseases. It is formulated to trigger an immune response in birds, enabling them to develop immunity against specific pathogens, including viruses and bacteria. The vaccination process can be administered through different routes, such as injection, aerosol, or in the drinking water of the birds. Vaccination programs are customized to the specific disease risks prevalent in a region, and they are an integral part of biosecurity measures on poultry farms. Additionally, farmers can effectively mitigate disease outbreaks and ensure the sustainable and safe production of poultry products, by utilizing appropriate poultry vaccines. Nowadays, poultry vaccines are essential in maintaining the health and welfare of poultry populations.

The market is primarily driven by the rising demand for biological products. In addition, the escalating demand for poultry products, including meat and eggs led to increased poultry production, thus influencing the market growth. In line with this, the growing poultry populations are necessitating the use of vaccines to protect the birds and maintain production levels, thus contributing to market growth. Moreover, the growing awareness among poultry farmers and producers about the importance of preventive healthcare measures, including vaccination, to ensure the well-being and productivity of their flocks represents another major growth-inducing factor. Along with this, vaccination is considered a cost-effective and efficient method to control and prevent the spread of infectious diseases, reducing the need for antibiotics and other treatments, thus propelling market growth. Besides this, the implementation of several government policies emphasizing the importance of food safety and animal welfare are accelerating the market growth. Furthermore, advancements in vaccine technology and research led to the development of more effective and targeted vaccines, improving their efficacy and safety profiles, thus creating a positive market outlook.

Poultry Vaccines Market Trends/Drivers:

The increasing poultry consumption

The rising demand for poultry products, such as chicken, meat, and eggs is influencing the poultry vaccines market outlook. In addition, the growing population, rapid urbanization, busy lifestyles of individuals are escalating the demand for poultry products, thus contributing to the market growth. Moreover, poultry farmers are turning to vaccination as a preventive measure to protect their flocks and ensure a steady supply of safe and disease-free products representing another major growth-inducing factor. Besides this, vaccines offer an effective and efficient way to protect poultry from infectious diseases, reducing the likelihood of outbreaks and associated production losses, thus accelerating market growth. Along with this, farmers can enhance bird health and productivity, leading to improved efficiency and profitability in the poultry industry by immunizing their flocks, thus propelling market growth. Apart from this, the rising poultry consumption has led to increased international trade of poultry and poultry products, thus propelling market growth.

The growing awareness regarding disease prevention

Another significant poultry vaccines market trends is the growing incidences of infectious diseases in poultry populations resulting in the widespread adoption of vaccines by farmers and producers to implement preventive measures to protect their flocks, thus influencing market growth. Moreover, farmers are increasingly investing in vaccination programs to safeguard their investments, control disease, and help reduce the incidence and severity of infectious diseases in poultry representing another major growth-inducing factor. Besides this, farmers can prevent disease spread and minimize production losses, ensuring a consistent supply of healthy poultry products to meet consumer demands by immunizing their flocks, thus accelerating market growth. Along with this, the increasing health-conscious and escalating demand for safe and high-quality food products is contributing to the production of safe and wholesome poultry products with the help of vaccines, thus propelling market growth. Furthermore, the growing awareness among consumers about the benefits of vaccinated poultry further drives the demand for poultry vaccines, encouraging producers to prioritize vaccination as a critical aspect of their disease prevention strategies.

The emerging technological advancements in vaccine development

The development of modern vaccines allows the production of vaccines with improved efficacy and longer-lasting immunity, providing better protection against numerous poultry diseases, thus contributing to poultry vaccines market growth. Moreover, the continuous development in biotechnology, innovative approaches, and techniques are leading to the creation of more effective, safe, and targeted poultry vaccines representing another major growth-inducing factor. Besides this, the extensive advancements in vaccine delivery systems, such as adjuvants and vector-based vaccines, poultry vaccines can now trigger a more robust and specific immune response thus accelerating the market growth. Along with this, these breakthroughs led to the development of customized vaccines that can address the specific needs of various poultry species and regional disease challenges, thus propelling market growth. Furthermore, advancements in vaccine formulation led to the creation of more stable and temperature-tolerant vaccines, enhancing their shelf life and reducing the need for cold chain storage and transportation leading to easier distribution and accessibility of vaccines to poultry farmers, especially in remote or resource-constrained regions, thus creating a positive market outlook.

Poultry Vaccines Industry Segmentation:

Breakup by Disease:

  • Infectious Bronchitis
  • Avian Influenza
  • Newcastle Disease
  • Marek's Disease
  • Others

Newcastle disease represents the most common disease

Newcastle disease (ND) is a highly contagious viral disease that affects various avian species, including chickens, turkeys, and pigeons, leading to severe economic losses in the poultry industry. In addition, newcastle disease is a primary concern for poultry farmers and producers due to rapid transmission and devastating impact on poultry flocks, thus influencing the market growth. Also, outbreaks of ND can result in high mortality rates, reduced egg production, and decreased feed conversion efficiency, leading to substantial financial losses for the poultry industry, thus augmenting market growth. Along with this, vaccination is essential for preventive measures for poultry producers, to help build immunity against the virus, reduce the severity of infections, and minimize the spread of the disease among flocks, thus propelling the market growth. Besides this, the regular and timely vaccination of poultry populations is essential to protect against ND outbreaks and maintain flock health, thus accelerating market growth. Apart from this, poultry farmers are relying on these vaccines to ensure the well-being of their flocks, secure their investments, and maintain a steady supply of disease-free poultry products to meet consumer demands, thus providing a positive thrust to the market growth.

Breakup by Product:

  • Recombinant Vaccine
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Subunit Vaccine
  • Others

Live attenuated vaccine represents the most popular product

Live attenuated vaccines are developed from weakened forms of pathogens that retain their ability to induce an immune response in the host without causing severe disease, thus contributing to market growth. Additionally, live attenuated vaccines have superior efficacy in providing long-lasting immunity against numerous poultry diseases, thus influencing market growth. These vaccines elicit humoral and cell-mediated immune responses, offering robust protection to poultry flocks. Moreover, live attenuated vaccines mimic natural infections, leading to a comprehensive and sustained immune defense, and can address several poultry diseases, including avian influenza, Newcastle disease, and infectious bronchitis representing another major growth-inducing factor. Besides this, live attenuated vaccines' ability to confer cross-protection against different strains of pathogens adds to their appeal among poultry farmers and producers, thus accelerating the market growth. Apart from their efficacy, live attenuated vaccines are generally cost-effective, making them an attractive choice for large-scale poultry production, thus propelling the market growth.

Breakup by Dosage Form:

  • Liquid Vaccine
  • Freeze Dried Vaccine

Liquid vaccine presently accounts for the largest market share

Liquid vaccines are known for their ease of administration and can be delivered through drinking water or by subcutaneous or intramuscular injection, making the vaccination process more straightforward and efficient. In addition, the ease of administration is particularly essential when vaccinating large flocks, as it minimizes the time and effort required for vaccination procedures, thus augmenting the market growth. Moreover, liquid vaccines offer better homogeneity and consistency in dosing, which are well-mixed in the vaccine solution, ensuring that each bird receives an accurate and uniform dose of the vaccine representing another major growth-inducing factor. This consistency is essential for achieving optimal immunization levels across the entire poultry population and maximizing the vaccine's efficacy.

Besides this, liquid vaccines can be more cost-effective than other dosage forms, as it involves lower manufacturing costs, and their efficient administration reduces the need for specialized equipment or additional labor, further accelerating the market growth. Furthermore, the convenience and reliability of liquid vaccines are contributing to their widespread adoption in the poultry industry as poultry farmers seek practical solutions to protect their flocks from diseases thus creating a positive market outlook.

Breakup by Application:

  • Breeder
  • Broiler
  • Layer

Broiler holds the leading position in the market

Broilers are chickens that are specifically raised for meat production thus accelerating the market growth. In addition, the escalating demand for broiler meat due to its affordability, versatility, and nutritional value is contributing to the market growth. As the global population continues to grow, there is a higher need for efficient and sustainable protein sources, making broiler meat an attractive option for consumers and food industries. Moreover, the intensive nature of broiler farming, with large-scale commercial production, necessitates a strong focus on disease prevention and biosecurity representing another major growth-inducing factor. Along with this, broilers raised in confined spaces are more susceptible to infectious diseases due to high stocking densities, making vaccination an essential aspect of their health management is propelling the market growth. Besides this, broilers have a shorter production cycle compared to other poultry species, such as layers (egg-laying hens). This means that a larger number of broilers are produced and processed within a shorter timeframe, leading to an escalating demand for poultry vaccines to protect these birds from potential disease outbreaks that could impact production and profitability, thus creating a positive market outlook.

Breakup by End User:

  • Veterinary Hospitals
  • Poultry Firm
  • Poultry Vaccination Center

Veterinary hospitals are essential in the distribution and administration of poultry vaccines. They are essential in providing medical care and advice to poultry farmers and producers. In addition, they offer expertise in diagnosing diseases, prescribing suitable vaccines, and administering vaccinations to poultry flocks, thus contributing to the market growth. These establishments act as trusted sources of information and are pivotal in promoting the adoption of vaccination practices among poultry farmers.

Moreover, poultry firms, including commercial poultry farms and integrated poultry companies, are significant consumers of poultry vaccines. These firms manage large-scale poultry operations and are highly invested in ensuring the health and productivity of their flocks. Along with this, vaccination is an integral part of their disease prevention and biosecurity strategies, as it helps protect the entire poultry population from infectious diseases, thus providing a positive thrust to the market growth. Poultry firms procure vaccines in bulk to immunize their vast flocks and minimize the risk of disease outbreaks that could lead to substantial production losses, thus influencing the market growth.

Besides this, poultry vaccination centers are specialized facilities dedicated to administering vaccines to poultry. These centers may be operated by private entities or government agencies. They cater to the needs of small-scale poultry farmers and backyard poultry keepers who may not have access to veterinary hospitals or lack expertise in vaccination procedures, thus accelerating the market growth. Poultry vaccination centers provide convenient access to vaccines, offer vaccination services, and assist in implementing proper vaccination schedules to ensure the health and well-being of the birds.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is driven by the presence of advanced poultry farming practices, robust biosecurity measures, and a high level of awareness about disease prevention among poultry farmers, thus influencing market growth. In addition, the United States and Canada are the major contributors to the escalating demand for poultry vaccines, as these countries boast well-established poultry industries with a focus on modern production techniques and stringent biosecurity standards, thus accelerating market growth. Moreover, the widespread adoption of advanced vaccination programs is essential in protecting poultry flocks from infectious diseases, ensuring a continuous and reliable supply of poultry products to meet consumer demands, representing another major growth-inducing factor.

Besides this, in Europe market, countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed poultry industries that prioritize disease prevention through vaccination, thus augmenting market growth. Along with this, in the Asia Pacific market, countries such as China, India, and Brazil are witnessing substantial growth in poultry production and consumption. As these regions experience an increase in poultry farming activities, there is a growing demand for poultry vaccines to mitigate disease risks and ensure the health and productivity of poultry flocks, thus creating a positive market outlook.

Key Regional Takeaways:

United States Poultry Vaccines Market Analysis

The United States market for poultry vaccines is growing steadily due to growing poultry production, rising rates of avian diseases, and increased awareness of biosecurity practices. Advanced veterinary infrastructure in the country and government drives for disease prevention favor extensive use of vaccines. Recombinant and vector-based vaccines with enhanced efficacy are where major players are putting their focus on. Besides, the need for antibiotic substitutes is directing the poultry industry towards vaccination as a pre-emptive health strategy. The American poultry industry, particularly broiler production, continues to be strong, maintaining steady demand for vaccines covering diseases such as Newcastle disease, infectious bronchitis, and avian influenza. Market consolidation and strategic alliances among large pharmaceutical firms are increasing distribution and R&D strengths. In addition, supportive regulations by institutions such as the USDA and FDA streamline vaccine approval, encouraging product development. In total, the U.S. poultry vaccines market is poised for continued growth driven by technological innovation, robust production levels, and an increasingly dynamic disease environment that requires frequent immunization regimes.

Europe Poultry Vaccines Market Analysis

Europe's poultry vaccines industry is marked by strict animal health laws and high food safety awareness, which fosters a highly regulated and mature market. Germany, France, and the Netherlands dominate the market through effective poultry farming practices and aggressive disease control measures. The region's emphasis on the reduction of antibiotics in livestock production has fueled the shift towards preventive vaccination methods. New-age technologies like recombinant DNA vaccines and vector-based platforms are picking up pace, particularly in treating respiratory and viral illnesses. The European Medicines Agency (EMA) acts as the key to ensuring veterinary vaccine safety and efficacy, offering a strong regulatory landscape. Cross-border disease management programs and traceability systems also improve the efficiency of deploying vaccines. There also exists cooperation between research organizations and pharmaceutical firms, leading to innovation. In all, the European poultry vaccines market is predicted to continue growing steadily, fueled by regulatory support, technology integration, and environmentally friendly livestock farming.

Asia Pacific Poultry Vaccines Market Analysis

The Asia Pacific poultry vaccines market is growing at a fast pace, driven by growing poultry farming, increasing meat consumption, and recurring disease outbreaks. China, India, and Indonesia are the main contributors of these, since demand is being fueled by government immunization campaigns and greater awareness. Rising investments in poultry health infrastructure and the transformation to commercial poultry production further support market growth. Vaccine formulation and cold chain technology advances are also improving reach and effectiveness. The region's extensive and varied poultry population makes it an important market for preventive and therapeutic vaccines alike.

Latin America Poultry Vaccines Market Analysis

In Latin America, the poultry vaccines market is expanding steadily, driven by increasing poultry production and export demand. Brazil and Mexico lead the region due to their large-scale commercial poultry operations and strong veterinary frameworks. Disease outbreaks such as avian influenza have emphasized the need for effective immunization, boosting vaccine uptake. Growing investment in poultry healthcare, along with regional government support and awareness campaigns, are contributing to market growth. Advancements in vaccine technologies and improved access in rural areas are further enhancing market penetration.

Middle East and Africa Poultry Vaccines Market Analysis

The Middle East and Africa poultry vaccines market is growing, supported by rising poultry consumption and improved awareness of disease control. Countries such as South Africa, Saudi Arabia, and Egypt are prominent markets, driven by government-led health initiatives and growing commercial farming. Despite challenges like limited cold chain infrastructure, increasing adoption of cost-effective and thermostable vaccines is aiding expansion. International partnerships and donor-backed programs also play a key role in boosting vaccine availability and adoption, particularly in rural and underserved regions.

Competitive Landscape:

Nowadays, key players in the market are implementing various strategies to strengthen their position and gain a competitive edge in the industry. They are investing in research and development (R&D) to develop advanced and more effective poultry vaccines and exploring new technologies and innovative approaches to enhance vaccine efficacy, safety, and duration of immunity. Moreover, companies are forming strategic collaborations and partnerships with other industry stakeholders, such as research institutions, universities, and poultry associations, allowing companies to stay at the forefront of vaccine development and stay ahead of the competition. Besides this, key players are catering to a broader range of poultry diseases and species and expanding their product portfolios by introducing new vaccines targeting specific pathogens and adopting a more personalized approach to address regional disease challenges.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AniCon Labor GmbH (SAN Group) Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco
  • Hester Biosciences Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Venkys India
  • Zoetis Inc.

Recent Developments:

  • In April 2025, India's Department of Animal Husbandry & Dairying has launched a three-pronged strategy to combat Bird Flu, focusing on stricter biosecurity, enhanced surveillance, and mandatory poultry farm registration. A national meeting also approved the commercial use of the H9N2 vaccine and explored future HPAI vaccination options. The government emphasized predictive modelling and scientific assessments to safeguard poultry health, food security, and rural livelihoods across the country.
  • In November 2024, Boehringer Ingelheim introduced a next-generation vaccine for Marek's disease in India, offering early, long-lasting protection for embryonated eggs and day-old chicks. Utilizing a serotype-1 construct with controlled attenuation, the vaccine balances safety and efficacy. It aims to reduce disease impact, boost flock health, and support poultry farmers' productivity. Experts highlight its role in combating increasing virus virulence and improving immune response in young birds.
  • In January 2020, Boehringer Ingelheim International GmbH introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). They produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.
  • In October 2022, Zoetis Inc. launched Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that offers early/robust protection against infectious bursal, Marek's, and Newcastle disease viruses with one dose, while expanding its poultry vaccine portfolio.
  • In April 2022, Elanco, in collaboration with Ginkgo Bioworks, introduced a new animal healthcare company called BiomEdit to develop nutritional products, drugs, and disease-monitoring methods for livestock which aim to address antibiotic resistance and improve sustainability.

Key Questions Answered in This Report

  • 1.What was the size of the global poultry vaccines market in 2024?
  • 2.What is the expected growth rate of the global poultry vaccines market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global poultry vaccines market?
  • 4.What are the key factors driving the global poultry vaccines market?
  • 5.What is the breakup of the global poultry vaccines market based on the disease?
  • 6.What is the breakup of the global poultry vaccines market based on the product?
  • 7.What is the breakup of the global poultry vaccines market based on the dosage form?
  • 8.What is the breakup of the global poultry vaccines market based on the application?
  • 9.What are the key regions in the global poultry vaccines market?
  • 10.Who are the key players/companies in the global poultry vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Poultry Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease

  • 6.1 Infectious Bronchitis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Avian Influenza
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Newcastle Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Marek's Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Recombinant Vaccine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated Vaccine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated Vaccine
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit Vaccine
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Liquid Vaccine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Freeze Dried Vaccine
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Breeder
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Broiler
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Layer
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Veterinary Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Poultry Firm
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Poultry Vaccination Center
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AniCon Labor GmbH (SAN Group)
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Biovac Ltd.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Boehringer Ingelheim International GmbH
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Ceva Sante Animale
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Elanco
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Hester Biosciences Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Merck & Co. Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Phibro Animal Health Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Venkys India
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Zoetis Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Poultry Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Poultry Vaccines Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Poultry Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Poultry Vaccines Market: Breakup by Disease (in %), 2024
  • Figure 5: Global: Poultry Vaccines Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Poultry Vaccines Market: Breakup by Dosage Form (in %), 2024
  • Figure 7: Global: Poultry Vaccines Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Poultry Vaccines Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Poultry Vaccines Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Poultry Vaccines (Infectious Bronchitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Poultry Vaccines (Infectious Bronchitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Poultry Vaccines (Avian Influenza) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Poultry Vaccines (Avian Influenza) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Poultry Vaccines (Newcastle Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Poultry Vaccines (Newcastle Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Poultry Vaccines (Marek's Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Poultry Vaccines (Marek's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Poultry Vaccines (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Poultry Vaccines (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Poultry Vaccines (Recombinant Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Poultry Vaccines (Recombinant Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Poultry Vaccines (Live Attenuated Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Poultry Vaccines (Live Attenuated Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Poultry Vaccines (Inactivated Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Poultry Vaccines (Inactivated Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Poultry Vaccines (Subunit Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Poultry Vaccines (Subunit Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Poultry Vaccines (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Poultry Vaccines (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Poultry Vaccines (Liquid Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Poultry Vaccines (Liquid Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Poultry Vaccines (Freeze Dried Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Poultry Vaccines (Freeze Dried Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Poultry Vaccines (Breeder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Poultry Vaccines (Breeder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Poultry Vaccines (Broiler) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Poultry Vaccines (Broiler) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Poultry Vaccines (Layer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Poultry Vaccines (Layer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Poultry Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Poultry Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Poultry Vaccines (Poultry Firm) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Poultry Vaccines (Poultry Firm) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Poultry Vaccines (Poultry Vaccination Center) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Poultry Vaccines (Poultry Vaccination Center) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: North America: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: North America: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: United States: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: United States: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Canada: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Canada: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Asia-Pacific: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Asia-Pacific: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: China: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: China: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Japan: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Japan: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: India: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: India: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: South Korea: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: South Korea: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Australia: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Australia: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Indonesia: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Indonesia: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Europe: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Europe: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Germany: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Germany: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: France: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: France: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: United Kingdom: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: United Kingdom: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Italy: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Italy: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Spain: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Spain: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Russia: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Russia: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Latin America: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Latin America: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Brazil: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Brazil: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Mexico: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Mexico: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Others: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Others: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Middle East and Africa: Poultry Vaccines Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Middle East and Africa: Poultry Vaccines Market: Breakup by Country (in %), 2024
  • Figure 94: Middle East and Africa: Poultry Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Global: Poultry Vaccines Industry: SWOT Analysis
  • Figure 96: Global: Poultry Vaccines Industry: Value Chain Analysis
  • Figure 97: Global: Poultry Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Poultry Vaccines Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Poultry Vaccines Market Forecast: Breakup by Disease (in Million USD), 2025-2033
  • Table 3: Global: Poultry Vaccines Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Poultry Vaccines Market Forecast: Breakup by Dosage Form (in Million USD), 2025-2033
  • Table 5: Global: Poultry Vaccines Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Poultry Vaccines Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Poultry Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Poultry Vaccines Market: Competitive Structure
  • Table 9: Global: Poultry Vaccines Market: Key Players